|
Market Closed -
Toronto S.E.
21:48:55 11/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 0.4450 CAD | -1.11% |
|
-5.32% | -2.20% |
| 08-27 | Pharmacorp Rx Inc. Announces Board and Committee Changes, Effective from August 31, 2026 | CI |
| 08-20 | PharmaCorp Rx Swings to Q2 Profit as Revenue Jumps | MT |
Main competitors
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
 | - | - | 44.5x | - | 1.66x | 20.7x | 48.57x | 55.84M | |
| -.--% | -.--% | 15.84x | 1.43x | 0.61x | 9.13x | 9.93x | 14.13B | |
| 2.33% | 2.67% | 16.01x | 1.65x | 0.71x | 7.45x | 9.34x | 6.33B | |
| 1.11% | 1.39% | 20.08x | 2.22x | 0.75x | 12.66x | 12.9x | 6.22B | |
| 2.92% | 3.34% | 14.48x | 2.14x | 0.88x | 6.19x | 8.28x | 4.06B | |
| 5.64% | 6.2% | 14.26x | 4.32x | 1.23x | 7.5x | 14.06x | 3.17B | |
| 5.32% | 5.89% | 13.58x | 2.57x | 0.57x | 4.39x | 7.24x | 3B | |
| 5.03% | 5.52% | 12.92x | 5.8x | 0.77x | 5.75x | 8x | 2.7B | |
| 2.21% | 2.63% | 18.37x | 3.21x | 0.55x | 7.02x | 11.49x | 1.37B | |
| 0.02% | -.--% | -108.04x | 2.24x | 0.38x | 13.7x | 49.39x | 1.25B | |
| 3.31% | 4.52% | 13.87x | 0.84x | 0.29x | 2.68x | 6.85x | 932M | |
| 6.03% | 5.28% | 20.47x | 2.41x | 0.83x | 7.63x | 18.16x | 877M | |
| 1.35% | 1.96% | 26.48x | 7.22x | 0.96x | 13.07x | 20.26x | 795M | |
| Average | 2.94% | 3.28% | 9.45x | 3.00x | 0.78x | 9.07x | 17.27x | 3.45B | |
| Weighted average by Cap. | 2.08% | 2.35% | 12.79x | 2.37x | 0.72x | 8.46x | 11.58x |
- Stock Market
- Stocks
- PCRX Stock
- Sector PharmaCorp Rx Inc.
- Sector dividends
Select your edition
All financial news and data tailored to specific country editions
